Bajaj Healthcare Share Price

  • 389.15-0.31 (-0.08%)
  • Volume: 1,16,025
  • Closed
  • Last Updated On: 30 Aug, 2024, 03:54 PM IST
Loading...

Bajaj Healthcare Share ...

  • 389.15-0.31 (-0.08%)
  • Volume: 1,16,025
Advertisment

Bajaj Healthcare share price insights

View All
  • Company has posted a profit of Rs 7.13 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)

  • Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

  • Company has spent 6.27% of its operating revenues towards interest expenses and 9.26% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

  • Bajaj Healthcare Ltd. share price moved down by -0.08% from its previous close of Rs 389.45. Bajaj Healthcare Ltd. stock last traded price is 389.15

    Share PriceValue
    Today/Current/Last389.15
    Previous Day389.45389.00

InsightsBajaj Healthcare

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    -37.75
    EPS - TTM
    (₹)
    -10.31
    MCap
    (₹ Cr.)
    1,073.99
    Sectoral MCap Rank
    76
    PB Ratio
    (x)
    3.86
    Div Yield
    (%)
    0.26
    Face Value
    (₹)
    5.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    389.94
    52W H/L
    (₹)
    513.40 / 263.30

    Bajaj Healthcare Share Price Returns

    1 Day-0.08%
    1 Week-5.11%
    1 Month1.49%
    3 Months33.52%
    1 Year3.7%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Bajaj Healthcare belongs to analysts' top-rated companies list?

    View Stock Screeners

    Bajaj Healthcare Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Bajaj Healthcare Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Bajaj Healthcare Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • PAT: Entering the Green

        Company has posted a profit of Rs 7.13 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent 6.27% of its operating revenues towards interest expenses and 9.26% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income133.10140.35109.37102.43129.95
      Total Income Growth (%)-5.1728.336.78-21.18-18.35
      Total Expenses114.47169.4996.3988.92114.30
      Total Expenses Growth (%)-32.4675.848.40-22.20-22.14
      EBIT18.63-29.1412.9813.5115.66
      EBIT Growth (%)--324.49-3.91-13.7226.64
      Profit after Tax (PAT)7.13-29.92-2.20-3.46-48.21
      PAT Growth (%)-----1,442.04
      EBIT Margin (%)14.00-20.7611.8713.1912.05
      Net Profit Margin (%)5.36-21.32-2.01-3.38-37.10
      Basic EPS (₹)2.59-10.84-0.80-1.25-17.47
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue482.10674.89681.33663.90413.19
      Total Revenue Growth (%)-28.57-0.952.6360.6811.33
      Total Expenses454.45616.67591.65545.08380.74
      Total Expenses Growth (%)-26.314.238.5443.169.73
      Profit after Tax (PAT)-83.7943.0271.3983.1122.50
      PAT Growth (%)-294.76-39.73-14.11269.3837.95
      Operating Profit Margin (%)12.1112.0415.0419.349.48
      Net Profit Margin (%)-17.696.3910.4912.655.48
      Basic EPS (₹)-30.3615.5925.8760.2316.31

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets765.13901.46721.10525.63325.75
      Total Assets Growth (%)-15.1225.0137.1961.3622.07
      Total Liabilities486.77533.77392.62267.22174.14
      Total Liabilities Growth (%)-8.8135.9546.9353.4526.43
      Total Equity278.36367.69328.49258.41151.61
      Total Equity Growth (%)-24.2911.9327.1270.4417.43
      Current Ratio (x)1.161.171.241.411.23
      Total Debt to Equity (x)1.191.130.780.650.64
      Contingent Liabilities0.0015.9715.1215.358.07

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 11.24 cr for investing activities which is an YoY decrease of 87.96%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities92.29-22.320.6943.5620.57
      Net Cash used in Investing Activities-11.24-93.43-74.80-108.93-27.56
      Net Cash flow from Financing Activities-96.60131.5061.8575.463.28
      Net Cash Flow-15.5515.75-12.2710.08-3.70
      Closing Cash & Cash Equivalent2.1717.721.9714.244.16
      Closing Cash & Cash Equivalent Growth (%)-87.73797.28-86.13242.46-47.10
      Total Debt/ CFO (x)3.60-18.56374.253.863.46

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-30.1011.7021.7332.1620.08
      Return on Capital Employed (%)16.3717.4225.6337.0521.67
      Return on Assets (%)-10.954.779.8915.816.90
      Interest Coverage Ratio (x)2.864.749.5015.326.03
      Asset Turnover Ratio (x)0.570.831.09124.98125.86
      Price to Earnings (x)-9.6319.5713.187.8312.63
      Price to Book (x)2.902.292.862.522.53
      EV/EBITDA (x)13.3811.419.965.626.88
      EBITDA Margin (%)17.9416.1017.6421.8012.44

      No reported Financial Ratios are available.

    Financial InsightsBajaj Healthcare

    • Income (P&L)
    • Cash Flow
      • PAT: Entering the Green

        Company has posted a profit of Rs 7.13 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 6.27% of its operating revenues towards interest expenses and 9.26% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Decrease in Cash from Investing

        Company has used Rs 11.24 cr for investing activities which is an YoY decrease of 87.96%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Bajaj Healthcare Peer Comparison

    • Bajaj Healthcare Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Bajaj Healthcare-37.753.86-30.1016.37-10.95-10.0212.11-17.69-30.361.161.193.60
      Syncom Form67.926.728.7812.896.253.1714.599.610.342.580.25-12.17
      Kopran Ltd24.312.9310.3714.516.857.1912.388.2910.572.080.202.29
      Lincoln Pharma14.482.3915.7320.3413.3212.5521.3016.0746.584.840.000.02
      Panacea Biotec-49.551.64-0.13-3.32-0.09-2.66-5.53-0.26-0.191.570.02-209.90
      Add More
      Annual Ratios (%)

      Choose from Peers

      • NGL Fine Chem
      • Bliss GVS Pharma
      • Jagsonpal Pharm
      • Albert David
      • Ind-Swift Labs

      Choose from Stocks

      Peers InsightsBajaj Healthcare

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Bajaj Healthcare Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Bajaj Healthcare Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters67.7367.7367.7367.69
        Pledge0.000.000.000.00
        FII0.000.530.740.66
        DII0.000.430.480.43
        Mutual Funds0.000.000.000.00
        Others32.2631.3031.0431.22
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters1,86,93,04267.73 %0.00
        Pledge00.00 %0.00
        FII1,5400.00 %-0.53
        DII6260.00 %-0.43
        MF1260.00 %0.00
        Others89,03,19232.26 %0.96

      MF Ownership

      MF Ownership as on 31 July 2024

      Corporate Actions

      • Bajaj Healthcare Board Meeting/AGM

      • Bajaj Healthcare Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 14, 2024Aug 08, 2024Board MeetingQuarterly Results & ESOP
        Jul 10, 2024Jul 05, 2024Board MeetingPreferential issue of shares
        May 24, 2024May 16, 2024Board MeetingAudited Results & Final Dividend
        Feb 09, 2024Feb 05, 2024Board MeetingQuarterly Results
        Nov 09, 2023Nov 03, 2023Board MeetingQuarterly Results
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final20%1.0Sep 22, 2023May 30, 2023
        Final30%1.5Sep 22, 2022May 17, 2022
        Special5%0.5Sep 28, 2021Jun 10, 2021
        Final5%0.5Sep 28, 2021Jun 09, 2021
        Final20%1.0-May 24, 2024
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsSep 28, 2021Sep 29, 2021Aug 13, 2021Split: Old FV10.0| New FV:5.0
        BonusApr 09, 2019Apr 10, 2019Feb 19, 2019Bonus Ratio: 1 share(s) for every 1 shares held

      About Bajaj Healthcare

      Bajaj Healthcare Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,074.82 Crore) operating in Pharmaceuticals sector. Bajaj Healthcare Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • SR

        Sajankumar R Bajaj

        Chairman & Managing Director
        AC

        Anil C Jain

        Managing Director
        RH

        Rupesh H Nikam

        WholeTime Director & CFO
        DS

        Dhananjay S Halte

        Whole Time Director
        Show More
      • Chaturvedi & Agrawal
        Paresh Rakesh & Associates

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times